1. Home
  2. PBPB vs ALLO Comparison

PBPB vs ALLO Comparison

Compare PBPB & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBPB
  • ALLO
  • Stock Information
  • Founded
  • PBPB 1977
  • ALLO 2017
  • Country
  • PBPB United States
  • ALLO United States
  • Employees
  • PBPB N/A
  • ALLO N/A
  • Industry
  • PBPB Restaurants
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PBPB Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • PBPB Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • PBPB 305.0M
  • ALLO 277.8M
  • IPO Year
  • PBPB 2013
  • ALLO 2018
  • Fundamental
  • Price
  • PBPB $11.54
  • ALLO $1.23
  • Analyst Decision
  • PBPB Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • PBPB 3
  • ALLO 9
  • Target Price
  • PBPB $15.67
  • ALLO $8.44
  • AVG Volume (30 Days)
  • PBPB 190.9K
  • ALLO 2.5M
  • Earning Date
  • PBPB 08-07-2025
  • ALLO 08-06-2025
  • Dividend Yield
  • PBPB N/A
  • ALLO N/A
  • EPS Growth
  • PBPB 1009.90
  • ALLO N/A
  • EPS
  • PBPB 1.39
  • ALLO N/A
  • Revenue
  • PBPB $465,126,000.00
  • ALLO N/A
  • Revenue This Year
  • PBPB $4.74
  • ALLO N/A
  • Revenue Next Year
  • PBPB $4.48
  • ALLO $199.63
  • P/E Ratio
  • PBPB $8.28
  • ALLO N/A
  • Revenue Growth
  • PBPB N/A
  • ALLO N/A
  • 52 Week Low
  • PBPB $6.28
  • ALLO $0.86
  • 52 Week High
  • PBPB $13.48
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • PBPB 63.95
  • ALLO 44.00
  • Support Level
  • PBPB $10.51
  • ALLO $1.27
  • Resistance Level
  • PBPB $11.26
  • ALLO $1.51
  • Average True Range (ATR)
  • PBPB 0.37
  • ALLO 0.11
  • MACD
  • PBPB -0.01
  • ALLO -0.00
  • Stochastic Oscillator
  • PBPB 94.47
  • ALLO 17.65

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: